These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 825097)

  • 1. Role of non-invasive methods in clinical evaluation of drugs in ischaemic heart disease.
    Chlebus H
    Bibl Cardiol; 1976; (35):167-71. PubMed ID: 825097
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trial of drugs affecting coronary insufficiency].
    Roskamm H; Schnellbacher K; Reindell H
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):53-60. PubMed ID: 4992897
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
    Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
    [No Abstract]   [Full Text] [Related]  

  • 5. Practolol in angina pectoris: a double-blind ergometric study.
    Bäckman H; Martikainen T
    Ann Clin Res; 1974 Dec; 6(6):347-55. PubMed ID: 4217578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Morgan JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4990005
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative exercise tolerance studies in patients with coronary insufficiency receiving practolol (author's transl)].
    Stauch M; Härich BK
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2287-92. PubMed ID: 4762829
    [No Abstract]   [Full Text] [Related]  

  • 9. The significance of some noninvasive methods in the objective evaluation of treatment of patients with coronary artery disease.
    Trakhtenberg SB
    Bibl Cardiol; 1976; (35):197-201. PubMed ID: 825099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of a static exercise test for evaluating anti-angina effects of drugs in patients with ischemic heart disease at a polyclinic].
    Gel'fgat EB; Muradova SA; Iagizarova NM; Abdullaeva IA
    Kardiologiia; 1988 Oct; 28(10):47-51. PubMed ID: 3147339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of practolol in the treatment of angina pectoris.
    Sen PK; Mukerjee AB
    J Indian Med Assoc; 1974 Oct; 63(8):260-1. PubMed ID: 4216606
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-angina and coronary dilating effect of low-dose nitroglycerin].
    Sievert H; Kober G; Schneider W; Kaltenbach M; Bussmann WD
    Z Kardiol; 1989; 78 Suppl 2():48-51; discussion 64-7. PubMed ID: 2511693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The exercise electrocardiogram: an objective method of evaluating the therapeutic efficacy of anti-angina drugs].
    Quiret JC; Rey JL; Courbet MT; Lantreibecq P; Lesbre JP; Bernasconi P
    Coeur Med Interne; 1978; 17(2):219-27. PubMed ID: 95917
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
    Sandler G; Clayton GA
    Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rational usage of orally administrated nitroglycerin in angina pectoris].
    Winsor T
    Lakartidningen; 1973 Oct; 70(40):3429-30. PubMed ID: 4207559
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Moran JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4988122
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coronary-dilating effect of minimal doses of nitroglycerin].
    Sievert H; Bussmann WD; Selzer G; Kober G; Kaltenbach M
    Z Kardiol; 1987 Oct; 76(10):626-9. PubMed ID: 3120436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of angina pectoris with beta receptor blockaders].
    Kaltenbach M; Becker HJ; Graef V; Hunscha H
    Med Klin; 1971 Mar; 65(11):494-500. PubMed ID: 4996983
    [No Abstract]   [Full Text] [Related]  

  • 19. [High-dose transdermal nitroglycerin therapy: loss of effect within 24 hours?].
    Reiniger G; Kraus F; Dirschinger J; Blasini R; Rudolph W
    Herz; 1985 Jun; 10(3):157-62. PubMed ID: 3926612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of 2 drug forms of nitroglycerin--transdermal (preparation Nitroderm-TTS) and gingival application (preparation Trinitrolong)--in ischemic heart disease patients].
    Metelitsa VI; Martsevich SIu; Piotrovskiĭ VK; Riabokon' OS; Blagodatskikh SV
    Ter Arkh; 1986; 58(6):58-62. PubMed ID: 3094187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.